Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_assertion type Assertion NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_head.
- NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_assertion description "[The case of the anaplastic lymphoma kinase (ALK) nicely exemplifies this, and cell line profiling has revealed that ALK mutations present in a subset of anaplastic large cell lymphomas (ALCLs), non-small cell lung cancers (NSCLCs), and neuroblastomas appear to sensitize cancer cells to treatment with selective ALK kinase inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_provenance.
- NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_assertion evidence source_evidence_literature NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_provenance.
- NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_assertion SIO_000772 19393834 NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_provenance.
- NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_assertion wasDerivedFrom befree-2016 NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_provenance.
- NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_assertion wasGeneratedBy ECO_0000203 NP734675.RAaDOf5pdyyZhdgTR17zx7Vesbq8OVUTn60fIyFj5nZMw130_provenance.